Open AccessImpact of a US Food and Drug Administration Drug Safety Communication on Zolpidem Dosing
Author(s) -
J. Harward,
Valerie B. Clinard,
Michael R. Jiroutek,
B. Lingerfeldt,
Andrew J. Muzyk
Publication year - 2015
Publication title -
primary care companion to cns disorders/the primary care companion for cns disorders
Language(s) - English
Resource type - Journals
eISSN - 2155-7772
pISSN - 2155-7780
DOI - 10.4088/pcc.14m01728
Subject(s) - zolpidem , drug , dosing , food and drug administration , pharmacology , medicine , drug administration , insomnia
Zolpidem is a sedative-hypnotic widely prescribed in the United States. Recently, the US Food and Drug Administration (FDA) issued a drug safety communication regarding its dosing in women.